UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046111
Receipt number R000052585
Scientific Title Confirmation of calcium absorption promoting action in mannooligosaccharides
Date of disclosure of the study information 2022/12/01
Last modified on 2023/04/25 07:12:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Confirmation of calcium absorption promoting action in mannooligosaccharides

Acronym

Confirmation of calcium absorption promoting action in mannooligosaccharides

Scientific Title

Confirmation of calcium absorption promoting action in mannooligosaccharides

Scientific Title:Acronym

Confirmation of calcium absorption promoting action in mannooligosaccharides

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The objective of this study is to confirm the promotion of calcium absorption by mannooligosaccharides intake.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Excreted urinary calcium

Key secondary outcomes

Urinary deoxypyridinoline
Urinary NTx


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Intake of test drink 1 once a day for 1week

Interventions/Control_2

Intake of test drink 2 once a day for 1week

Interventions/Control_3

Intake of placebo drink once a day for 1week

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >=

Gender

Female

Key inclusion criteria

(1)Healthy female aged 20-70 years
(2)Subjects who have received a sufficient explanation of the purpose and contents of the examination, have the ability to consent, have well understood, volunteered to participate, and have signed the informed consent document

Key exclusion criteria

(1)Subjects who affected from chronic illness and are taking drugs
(2)Subjects who have bone-related diseases
(3)Subjects who have a medical history of diseases such as malignant tumor, heart failure, myocardial infarction, arrhythmia, liver dysfunction, cerebrovascular disease, rheumatism, diabetes, dyslipidemia, hypertension, urinary stones, etc.
(4)Subjects who are taiking supplements (including foods for specified health use and foods with functional claims)
(5)Subjects who regularly drink milk
(6)Subjects working in night shifts
(7)Subjects who who always have diarrhea
(8)Subjects who have a history of gastrointestinal disorders and gastrointestinal surgery that affect gastrointestinal absorption
(9)Subjects who have allergies to food ingredients contained in test foods
(10)Subjects who are pregnant, breastfeeding, or willing to become pregnant
(11)Subjects who have collected more than 200 mL of blood within 12 weeks prior to the screening test
(12)Subjects who participate in other clinical trials (food, pharmaceuticals and cosmetics), who have participated in other tests within one month of obtaining consent, or who are willing to participate
(13)Subjects who are judged as unsuitable for the study by the investigators

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Yoshitaka
Middle name
Last name Iwama

Organization

Nihonbashi Cardiology Clinic

Division name

Director

Zip code

103-0001

Address

Kyodo Bldg. #201, 12-4 Nihonbashi Kodenmacho, Chuo-ku, Tokyo

TEL

03-5641-4133

Email

yiwama@well-sleep.jp


Public contact

Name of contact person

1st name Toshio
Middle name
Last name Kumao

Organization

Ajinomoto AGF, INC.

Division name

Technology Development Dept. Technical Research and Development Institute

Zip code

210-8681

Address

1-1, Suzuki-cho Kawasaki-ku, Kawasaki-shi Kanagawa Pref.

TEL

080-3721-4520

Homepage URL


Email

toshio.kumaoh.hv8@agf.co.jp


Sponsor or person

Institute

KSO Corporation

Institute

Department

Personal name



Funding Source

Organization

Ajinomoto AGF, INC.
Technology Development Dept.
Technical Research and Development Institute

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Committee of Kobuna Orthopedics Clinic

Address

311-2, Gokanmachi, maebashishi, Gunma

Tel

027-261-7600

Email

sagawa@mc-connect.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 10 Month 28 Day

Date of IRB

2021 Year 10 Month 28 Day

Anticipated trial start date

2021 Year 11 Month 15 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 11 Month 18 Day

Last modified on

2023 Year 04 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052585


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name